Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69926 - 69950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CGREF1	10669	upregulated	Silicon Dioxide analog results in increased expression of CGREF1 mRNA	2p23.3	A24194
Silicon dioxide	Approved	CH25H	9023	upregulated	Silicon Dioxide results in increased expression of CH25H mRNA	10q23.31	A24196
Silicon dioxide	Approved	CHAC1	79094	downregulated	Silicon Dioxide results in decreased expression of CHAC1 mRNA	15q15.1	A24196
Silicon dioxide	Approved	CHCHD7	79145	downregulated	Silicon Dioxide results in decreased expression of CHCHD7 mRNA	8q12.1	A24196
Silicon dioxide	Approved	CHEK2	11200	downregulated	Silicon Dioxide analog results in decreased expression of CHEK2 mRNA	22q12.1	A24195
Silicon dioxide	Approved	CHGB	1114	downregulated	Silicon Dioxide analog results in decreased expression of CHGB mRNA	20p12.3	A24195
Silicon dioxide	Approved	CHML	1122	upregulated	Silicon Dioxide analog results in increased expression of CHML mRNA	1q43	A24195
Silicon dioxide	Approved	CHORDC1	26973	upregulated	Silicon Dioxide results in increased expression of CHORDC1 mRNA	11q14.3	A24196
Silicon dioxide	Approved	CHRDL2	25884	downregulated	Silicon Dioxide analog results in decreased expression of CHRDL2 mRNA	11q13.4	A24195
Silicon dioxide	Approved	CHRM3	1131	downregulated	Silicon Dioxide analog results in decreased expression of CHRM3 mRNA	1q43	A24194 A24195
Silicon dioxide	Approved	CHRNA10	57053	upregulated	Silicon Dioxide analog results in increased expression of CHRNA10 mRNA	11p15.4	A24195
Silicon dioxide	Approved	CHRND	1144	downregulated	Silicon Dioxide analog results in decreased expression of CHRND mRNA	2q37.1	A24195
Silicon dioxide	Approved	CHST1	8534	downregulated	Silicon Dioxide results in decreased expression of CHST1 mRNA	11p11.2	A24196
Silicon dioxide	Approved	CHST11	50515	upregulated	Silicon Dioxide analog results in increased expression of CHST11 mRNA	12q23.3	A24195
Silicon dioxide	Approved	CHST2	9435	upregulated	Silicon Dioxide analog results in increased expression of CHST2 mRNA	3q24	A24195
Silicon dioxide	Approved	CHST2	9435	upregulated	Silicon Dioxide results in increased expression of CHST2 mRNA	3q24	A24196
Silicon dioxide	Approved	CHST6	4166	downregulated	Silicon Dioxide analog results in decreased expression of CHST6 mRNA	16q23.1	A24195
Silicon dioxide	Approved	CIART	148523	upregulated	Silicon Dioxide analog results in increased expression of CIART mRNA	1q21.2	A24195
Silicon dioxide	Approved	CIB4	130106	downregulated	Silicon Dioxide analog results in decreased expression of CIB4 mRNA	2p23.3	A24195
Silicon dioxide	Approved	CIDEB	27141	downregulated	Silicon Dioxide analog results in decreased expression of CIDEB mRNA	14q12	A24195
Silicon dioxide	Approved	CIDEB	27141	downregulated	Silicon Dioxide results in decreased expression of CIDEB mRNA	14q12	A24196
Silicon dioxide	Approved	CITED4	163732	upregulated	Silicon Dioxide analog results in increased expression of CITED4 mRNA	1p34.2	A24195
Silicon dioxide	Approved	CKAP2L	150468	upregulated	Silicon Dioxide analog results in increased expression of CKAP2L mRNA	2q14.1	A24194
Silicon dioxide	Approved	CKB	1152	downregulated	Silicon Dioxide analog results in decreased expression of CKB mRNA	14q32.33	A24195
Silicon dioxide	Approved	CKLF	51192	upregulated	Silicon Dioxide analog results in increased expression of CKLF mRNA	16q21	A24195

Displaying entries 69926 - 69950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability